Concepedia

Jianxin Wang

JW

Statistics

Publications

3

Citations

91

H-Index

3

Active since

2022

Affiliations

Johns Hopkins Medicine(Current)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Bristol-Myers Squibb (United States)

Bloomberg (United States)

Jianxin Wang is an author at Johns Hopkins Medicine specializing in tumor microenvironment regulation, resistance to checkpoint inhibitors, and cancer immunotherapy.

ORCID

Publications per year

2022–2024

3

Publications

3

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

Jianxin Wang, May Tun Saung, Keyu Li et al. · The Journal of Experimental Medicine · 2022 · 64 citations · Full text

, , +17

Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-β depletion

Sophia Y. Chen, Heng‐Chung Kung, Birginia Espinoza et al. · JCI Insight · 2024 · 14 citations · Full text

, , +17

Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC

Jianxin Wang, Tengyi Zhang, Pan Li et al. · Cancer Letters · 2023 · 13 citations

, , +14

1–3 of 3